Paper28693269
Significance of E-cadherin and CD44 expression in patients with unresectable metastatic colorectal cancer.
Iseki Y and 5 others. Oncol Lett, 2017. Cited by 18 papers, by iCite.
Cite this record
ConductScience Library. Significance of E-cadherin and CD44 expression in patients with unresectable metastatic colorectal cancer. Papers, record 28693269. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28693269
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Significance of E-cadherin and CD44 expression in patients with unresectable metastatic colorectal cancer.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References40
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21678109 | Prognostic significance of Wnt-1, β-catenin and E-cadherin expression in advanced colorectal carcinoma. | Pathol Oncol Res | 2011 | https://conductscience.org/library/papers/21678109 | PubMed |
| 2 | 9395530 | Variant exons v6 and v7 together expand the repertoire of glycosaminoglycans bound by CD44. | J Biol Chem | 1997 | https://conductscience.org/library/papers/9395530 | PubMed |
| 3 | 8780391 | Progressive loss of CD44 gene expression in invasive bladder cancer. | Am J Pathol | 1996 | https://conductscience.org/library/papers/8780391 | PubMed |
| 4 | 12398894 | A signaling pathway leading to metastasis is controlled by N-cadherin and the FGF receptor. | Cancer Cell | 2002 | https://conductscience.org/library/papers/12398894 | PubMed |
| 5 | 16857785 | Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines. | Clin Cancer Res | 2006 | https://conductscience.org/library/papers/16857785 | PubMed |
| 6 | 24503029 | Cancer incidence and incidence rates in Japan in 2008: a study of 25 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project. | Jpn J Clin Oncol | 2014 | https://conductscience.org/library/papers/24503029 | PubMed |
| 7 | 2193100 | Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. | J Exp Med | 1990 | https://conductscience.org/library/papers/2193100 | PubMed |
| 8 | 11733201 | Tumor environment: a potent driving force in colorectal cancer? | Trends Mol Med | 2001 | https://conductscience.org/library/papers/11733201 | PubMed |
| 9 | 19262571 | Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. | Nat Rev Cancer | 2009 | https://conductscience.org/library/papers/19262571 | PubMed |
| 10 | 10931041 | E-cadherin-catenin cell-cell adhesion complex and human cancer. | Br J Surg | 2000 | https://conductscience.org/library/papers/10931041 | PubMed |
| 11 | 23923027 | Downregulated E-cadherin expression indicates worse prognosis in Asian patients with colorectal cancer: evidence from meta-analysis. | PLoS One | 2013 | https://conductscience.org/library/papers/23923027 | PubMed |
| 12 | 25088940 | FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial. | Lancet Oncol | 2014 | https://conductscience.org/library/papers/25088940 | PubMed |
| 13 | 9155672 | Tumour recurrence is associated with Jass grouping but not with differences in E-cadherin expression in moderately differentiated Dukes' B colorectal cancers. | J Clin Pathol | 1997 | https://conductscience.org/library/papers/9155672 | PubMed |
| 14 | 22692571 | Prognostic scoring system for stage IV colorectal cancer: is the AJCC sub-classification of stage IV colorectal cancer appropriate? | Int J Clin Oncol | 2013 | https://conductscience.org/library/papers/22692571 | PubMed |
| 15 | 2466576 | A human lymphocyte homing receptor, the hermes antigen, is related to cartilage proteoglycan core and link proteins. | Cell | 1989 | https://conductscience.org/library/papers/2466576 | PubMed |
| 16 | 17673689 | Collagen I promotes epithelial-to-mesenchymal transition in lung cancer cells via transforming growth factor-beta signaling. | Am J Respir Cell Mol Biol | 2008 | https://conductscience.org/library/papers/17673689 | PubMed |
| 17 | 18322269 | Cadherin switching. | J Cell Sci | 2008 | https://conductscience.org/library/papers/18322269 | PubMed |
| 18 | 10211089 | Immunohistological analysis of E-cadherin, alpha-, beta- and gamma-catenin expression in colorectal cancer: implications for cell adhesion and signaling. | Eur J Cancer | 1999 | https://conductscience.org/library/papers/10211089 | PubMed |
| 19 | 2056274 | Molecular cloning of CD44R1 and CD44R2, two novel isoforms of the human CD44 lymphocyte "homing" receptor expressed by hemopoietic cells. | J Exp Med | 1991 | https://conductscience.org/library/papers/2056274 | PubMed |
| 20 | 15339042 | CD44 in cancer progression: adhesion, migration and growth regulation. | J Mol Histol | 2004 | https://conductscience.org/library/papers/15339042 | PubMed |
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41413092 | CD44 and phosphorylated ERK1/2 coexpression predicts distant metastasis in colorectal cancer based on a study of 1137 Saudi patients. | Sci Rep | 2025 | https://conductscience.org/library/papers/41413092 | PubMed |
| 39174579 | The use of hyaluronic acid in a 3D biomimetic scaffold supports spheroid formation and the culture of cancer stem cells. | Sci Rep | 2024 | https://conductscience.org/library/papers/39174579 | PubMed |
| 37012965 | Association Between the Immunohistochemistry Expression of E-cadherin, Beta-Catenin, and CD44 in Colorectal Adenocarcinoma. | Cureus | 2023 | https://conductscience.org/library/papers/37012965 | PubMed |
| 35732878 | Effect of E-cadherin on Prognosis of Colorectal Cancer: A Meta-Analysis Update. | Mol Diagn Ther | 2022 | https://conductscience.org/library/papers/35732878 | PubMed |
| 33817713 | Assessment of mismatch repair deficiency, CDX2, beta-catenin and E-cadherin expression in colon cancer: molecular characteristics and impact on prognosis and survival - an immunohistochemical study. | Rom J Morphol Embryol | 2020 | https://conductscience.org/library/papers/33817713 | PubMed |
| 33123252 | Tumour stem cell markers CD133 and CD44 are useful prognostic factors after surgical resection of pancreatic neuroendocrine tumours. | Oncol Lett | 2020 | https://conductscience.org/library/papers/33123252 | PubMed |
| 32392708 | The Extracellular Matrix Influences Ovarian Carcinoma Cells' Sensitivity to Cisplatinum: A First Step towards Personalized Medicine. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32392708 | PubMed |
| 32025858 | Clinical implications of cancer stem cells in digestive cancers: acquisition of stemness and prognostic impact. | Surg Today | 2020 | https://conductscience.org/library/papers/32025858 | PubMed |
| 32021376 | The Association Between Inflammation, Epithelial Mesenchymal Transition and Stemness in Colorectal Carcinoma. | J Inflamm Res | 2020 | https://conductscience.org/library/papers/32021376 | PubMed |
| 31942198 | Death Domain-Associated Protein Promotes Colon Cancer Metastasis through Direct Interaction with ZEB1. | J Cancer | 2020 | https://conductscience.org/library/papers/31942198 | PubMed |
| 31114754 | The Prognostic and Clinical Value of CD44 in Colorectal Cancer: A Meta-Analysis. | Front Oncol | 2019 | https://conductscience.org/library/papers/31114754 | PubMed |
| 30717315 | Potential Applications of DNA, RNA and Protein Biomarkers in Diagnosis, Therapy and Prognosis for Colorectal Cancer: A Study from Databases to AI-Assisted Verification. | Cancers (Basel) | 2019 | https://conductscience.org/library/papers/30717315 | PubMed |
| 30021598 | Evaluation of the correlation of MACC1, CD44, Twist1, and KiSS-1 in the metastasis and prognosis for colon carcinoma. | Diagn Pathol | 2018 | https://conductscience.org/library/papers/30021598 | PubMed |
| 30008850 | Significance and prognosis of epithelial-cadherin expression in invasive breast carcinoma. | Oncol Lett | 2018 | https://conductscience.org/library/papers/30008850 | PubMed |
| 29115580 | Overexpression of CCDC34 in colorectal cancer and its involvement in tumor growth, apoptosis and invasion. | Mol Med Rep | 2018 | https://conductscience.org/library/papers/29115580 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD44 | 960 | PubTator's text mining | https://conductscience.org/library/genes/960 | NCBI Gene |
| CDH1 | 999 | PubTator's text mining | https://conductscience.org/library/genes/999 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28693269
GET https://conductscience.org/api/papers/v1/28693269/references?page=2